No Data
No Data
NRx Pharmaceuticals Unit Signs Letter of Intent to Acquire Neurospa TMS
Express News | Hope Therapeutics : Acquisition to Be Accretive to Hope Revenue Projections for 2025
Press Release: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Letter of Intent With Neurospa TMS Holdings, LLC for Expansion of Its Planned International Network of Interventional Psychiatry Clinics
8-K: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
H.C. Wainwright Maintains NRX Pharmaceuticals(NRXP.US) With Buy Rating, Maintains Target Price $19
NRX Pharmaceuticals Price Target Maintained With a $19.00/Share by HC Wainwright & Co.
Yubraj : @Jaguar8 brother how about TNON
Yubraj Yubraj : is it in your radar or not?
Jaguar8 OP Yubraj : Yes it is but it will be on stocks with news which i will post later. Still reviewing others stocks with news. It will be included for sure
Yubraj Jaguar8 OP : thank you
72149607 : what u think about VVPR jag bro pre market today?
View more comments...